===== Beginning: Policy Process Changes =====
In July 2023, the Beijing Municipal Medical Insurance Bureau took the lead in including 16 assisted reproductive technology procedures in the medical insurance reimbursement scope, becoming the first city in the country to implement this. Subsequently, provinces such as Guangxi, Gansu, Inner Mongolia, Xinjiang, Zhejiang (partial), and Jiangsu (partial) have successively introduced relevant policies. As of May 2025, more than 50 coordinated regions in over 12 provinces across the country have included some assisted reproductive procedures in medical insurance coverage, with the scope continuing to expand at the prefectural and municipal levels.
===== 1. Direct Answer =====I. Direct Answer: Can IVF Be Covered by Medical Insurance in China?
Yes, but with limitations. Currently, provinces and cities such as Beijing, Guangxi, Gansu, Inner Mongolia, Xinjiang, Zhejiang (Hangzhou, Ningbo, etc.), and Jiangsu (Nanjing, Suzhou, etc.) have clearly included some assisted reproductive technology procedures in the medical insurance reimbursement scope. The reimbursement rate is typically 50% to 70% for employee medical insurance and 40% to 50% for resident medical insurance, with annual or per-cycle caps set by each region. However, not all costs related to IVF are reimbursable. The reimbursement scope mainly focuses on examination items within the medical insurance catalog, ovulation induction drugs, egg retrieval surgery, embryo culture, embryo transfer, and ICSI (Intracytoplasmic Sperm Injection) and other core medical procedures. The reimbursement scope for third-generation IVF (PGT) is significantly narrower, with most regions only covering the genetic testing-related parts and requiring specific indications.
Medical insurance reimbursement must simultaneously meet the following basic conditions: meeting the diagnostic criteria for infertility (usually having regular unprotected sexual intercourse without conception for more than 1 year), seeking treatment at a medical insurance designated medical institution (i.e., an assisted reproductive designated hospital recognized by the local health commission), holding a valid medical insurance card with normal contributions, and meeting the local age requirements (most regions require the female partner to be ≤49 years old). Some regions also have restrictions on the first IVF cycle or the cumulative number of reimbursements.
===== 2. Policy Background =====II. Why This Change Occurred
The core driving forces behind including assisted reproductive technology in medical insurance come from three aspects. First, demographic changes: The infertility rate among the reproductive-age population in China has risen to about 18%, meaning approximately 1 in 6 couples face fertility difficulties. Second, upgraded fertility support policies: Since 2023, the national level has explicitly required all regions to improve fertility support measures, and assisted reproduction, as a medical fertility support method, has been included in the scope of medical insurance reform. Third, the need to reduce economic burden: The cost of a conventional IVF cycle ranges from 30,000 to 50,000 RMB, and third-generation IVF can cost 80,000 to 120,000 RMB. Medical insurance intervention can significantly reduce the patient's out-of-pocket ratio and increase treatment accessibility.
From the perspective of medical insurance fund operation, the decision to include assisted reproduction in medical insurance has undergone multiple rounds of expert论证 and fund calculations. When determining reimbursable items, local medical insurance bureaus have prioritized including technologically mature, transparently priced, and clinically clear-pathway items, while setting stricter access conditions for high-cost items (such as PGT). This policy trend is expected to cover more provinces in the next 2 to 3 years, but the pace of implementation varies across regions due to differences in fund affordability.
===== 3. Regional Policy Differences =====III. Policy Differences Across Regions
There are significant differences between regions in terms of reimbursement scope, rates, caps, and age limits. The table below summarizes the main policy points of key regions that have clearly implemented policies as of May 2025 (specific details are subject to the latest documents from the local medical insurance bureau):
| Region | Implementation Date | Employee Reimbursement Rate | Resident Reimbursement Rate | Cap/Annual Limit | Main Items Covered |
|---|---|---|---|---|---|
| Beijing | July 2023 | 70% | 50% | Limit per treatment cycle, accumulated by item | 16 items: egg retrieval, embryo culture, transfer, ICSI, freeze-thaw, etc. |
| Guangxi | November 2023 | 70% | 50% | Annual cap, approx. 15,000 RMB for employees | Partial items: egg retrieval, culture, transfer, sperm optimization, etc. |
| Gansu | February 2024 | 60% | 50% | Annual cap approx. 12,000 RMB | Partial items: egg retrieval, culture, transfer, ICSI, etc. |
| Inner Mongolia | January 2024 | 70% | 50% | Annual cap, approx. 13,000 RMB for employees | Partial items: egg retrieval, culture, transfer, frozen embryo thawing, etc. |
| Xinjiang | March 2024 | 60% | 50% | Annual cap approx. 10,000 RMB | Partial items: egg retrieval, culture, transfer, sperm processing, etc. |
| Zhejiang (Hangzhou, Ningbo, etc.) | Rollout from 2024 | 50%～70% | 40%～50% | Varies by city, approx. 10,000～18,000 RMB | Partial items: egg retrieval, culture, transfer, ICSI, etc. |
| Jiangsu (Nanjing, Suzhou, etc.) | Rollout from 2024 | 50%～70% | 40%～50% | Varies by city, approx. 10,000～15,000 RMB | Partial items: egg retrieval, culture, transfer, etc. |
Note: The above table is compiled from public information. Please refer to the latest announcements from the local medical insurance bureau and designated hospitals for specific implementation details.
===== 4. Differences Between Hospitals =====IV. Differences Between Hospitals
Another key variable in medical insurance reimbursement is the type of hospital. Currently, among the medical institutions in China that perform assisted reproductive technology, public tertiary hospitals are the main designated entities for medical insurance, and most have already enabled direct settlement. In contrast, some private fertility centers have not yet been included as medical insurance designated sites, or only the medication costs (requiring patients to go to designated pharmacies) can be reimbursed. Furthermore, even within the same city, the reimbursement rate is the same for hospitals of different levels (tertiary vs. secondary), but charging standards and the scope of reimbursable items may differ.
Before choosing a hospital, it is recommended to confirm through the following methods: ① Log in to the local medical insurance bureau's official website to check the list of designated assisted reproductive medical institutions; ② Call the hospital's medical insurance office to confirm the specific reimbursement process; ③ Present your medical insurance card proactively when visiting and indicate that you need medical insurance settlement. Some hospitals have dedicated pre-authorization windows for medical insurance patients, requiring relevant materials to be submitted in advance for eligibility review.
===== 5. Most Easily Overlooked Details =====V. Most Easily Overlooked Details
In practice, the following details are often overlooked by patients and directly affect the reimbursement outcome:
- Differences in Medical Insurance Type: The reimbursement rate between employee medical insurance and resident medical insurance can differ by 20 percentage points, and resident medical insurance usually has a lower cap. The reimbursement policy for self-employed individuals participating in insurance is the same as for employee medical insurance, but it is necessary to ensure that contributions are in a normal payment status.
- Annual Cap vs. Per-Cycle Limit: In some regions, the cap is calculated based on the calendar year, not the treatment cycle. If a cycle spans across years, the reimbursement amount may be recalculated, but it could also lead to changes in item codes due to the year transition, so it is necessary to confirm with the hospital's medical insurance office in advance.
- Limits on Reimbursement Times: A few regions impose limits on the total number of assisted reproductive reimbursements a participant can receive in their lifetime, such as "no more than 3 times in total" or "one cycle every 2 years."
- Age Threshold: Most regions require the female partner's age to be ≤49 years old, and some regions require ≤45 years old. There is usually no age limit for the male partner, but reimbursement for the male partner's examination items must comply with the medical insurance catalog.
- Pre-Reporting Requirements: Some cities require patients to register with the medical insurance center in advance before entering the treatment cycle, or have the hospital's medical insurance office upload relevant information; otherwise, direct settlement may not be possible. Failure to report may require manual post-treatment reimbursement, which involves a more complex process and stricter material requirements.
VI. Common Pitfalls
- Assuming all costs are reimbursable: Imported ovulation induction drugs, some adjuvant medications (e.g., growth hormone), assisted embryo hatching, PGT genetic testing fees, donor sperm/egg related costs, and non-medically necessary procedures (e.g., embryo sex selection) are not covered by reimbursement. Be sure to request a detailed list of medical insurance items before treatment.
- Ignoring the requirement for designated hospitals: Costs incurred at non-designated medical institutions cannot be reimbursed, even if the hospital has a fertility center. The reimbursement rate for referrals to other provinces is usually reduced by 20% to 30%, and advance registration for cross-provincial medical treatment is required.
- Not understanding the "Category B" self-pay ratio: Some assisted reproductive procedures are classified as Category B under medical insurance, requiring patients to pay a certain percentage (usually 10% to 30%) first, with the remaining portion then reimbursed according to the medical insurance rate. The actual reimbursement amount = (Item cost - Category B self-pay) × Reimbursement rate.
- Not verifying the medical insurance card status: An overdue, frozen, inactive medical insurance card, or one in a waiting period (e.g., new enrollees need to pay continuously for more than 6 months) will prevent normal reimbursement. Be sure to verify this before starting the treatment cycle.
- Misconceptions about third-generation IVF reimbursement: PGT reimbursement policies vary greatly across regions. Beijing only covers some genetic testing items within PGT, and only with clear medical indications (e.g., chromosomal abnormalities, single-gene disorder carriers); most regions do not reimburse PGT at all or only cover the conventional operational parts (e.g., egg retrieval, culture), with genetic testing costs being out-of-pocket.
VII. Actual Process: From Consultation to Reimbursement
The specific operational process for medical insurance reimbursement can be divided into the following steps, recommended to be followed in order:
- Confirm Eligibility and Policy: Call the local medical insurance hotline (12393) or log in to the medical insurance bureau's official website to confirm the assisted reproductive reimbursement policy, list of designated hospitals, reimbursement rate, and cap in your coordinated region.
- Choose a Designated Hospital and Make an Appointment: Select one from the published list of designated medical institutions and make an appointment for an initial consultation at the reproductive medicine center through official channels. Bring your ID card, medical insurance card, and previous examination records.
- Complete Infertility Diagnosis and Evaluation: The doctor will make a clear diagnosis based on medical history, physical examination, sex hormones, AMH, semen analysis, ultrasound, and other tests. Most of these basic examination items are within the medical insurance reimbursement scope.
- Medical Insurance Eligibility Review: The hospital's medical insurance office or reproductive center will assist in conducting a pre-authorization review of medical insurance eligibility, confirming that the patient meets the reimbursement conditions (age, diagnosis, insurance status, etc.), and uploading relevant information to the medical insurance system.
- Enter the Treatment Cycle: After the review is approved, the doctor will formulate an ovulation induction plan and begin procedures such as medication, monitoring, egg retrieval, culture, and transfer. Present your medical insurance card proactively at each payment point, and the system will automatically calculate the medical insurance payment portion and the out-of-pocket portion.
- Settlement and Reimbursement: Costs incurred during the treatment process are settled directly at the payment window. The medical insurance reimbursement portion is settled between the hospital and the medical insurance center, and the patient only pays the out-of-pocket and self-pay portions. Keep all settlement documents for verification.
- Supplementary Materials (if needed): Some items (e.g., manual post-treatment reimbursement) may require additional documents such as copies of medical records, expense lists, and diagnosis certificates, which should be submitted as required by the medical insurance center.
VIII. Factors Affecting Costs
For the same IVF procedure, the actual out-of-pocket costs for different patients vary greatly, mainly influenced by the following factors:
📍 Regional Differences
Different provinces have different reimbursement rates, caps, and item coverage, directly affecting the out-of-pocket amount. For example, Beijing employees are reimbursed at 70%, while Gansu employees are at 60%, resulting in a difference of about 5,000 to 8,000 RMB for the same cycle.
🏥 Hospital Level and Pricing
Charging standards at tertiary hospitals are usually higher than at secondary hospitals, but the reimbursement rate is the same. Although some private hospitals are designated, they may have fewer reimbursable items and a higher proportion of out-of-pocket costs.
💉 IVF Generation
First/second-generation IVF (IVF/ICSI) has a broader reimbursement scope; for third-generation IVF (PGT), the large genetic testing costs are usually out-of-pocket, with the overall out-of-pocket ratio reaching 60% to 80%.
🧪 Medication Plan
Domestic ovulation induction drugs (e.g., urinary gonadotropins) have good medical insurance coverage and low out-of-pocket costs; imported drugs (e.g., Gonal-f, Puregon) are partially Category B or fully self-pay, with a cost difference of up to 10,000 to 30,000 RMB.
❄️ Frozen Embryo Transfer or Not
Fresh embryo transfer costs are relatively low; frozen embryo transfer requires additional payment for freezing, thawing, and endometrial preparation costs. Some of these items may be reimbursable, while others are out-of-pocket.
🩺 Management of Comorbidities
Conditions such as endometriosis, hydrosalpinx, or uterine fibroids may require additional surgery or medication, and these costs are calculated separately according to the medical insurance catalog.
IX. Frequently Asked Questions
Q1: What materials are needed for medical insurance reimbursement?
Basic materials include: ID card, medical insurance card, fertility service certificate (or fertility registration certificate), infertility diagnosis certificate (issued by the reproductive center), expense list, and copies of medical records. Some regions require a marriage certificate. It is recommended to request a material checklist from the hospital's medical insurance office before your visit to prepare everything at once.
Q2: Can IVF be reimbursed if done in a different city/province?
Yes, but you need to complete cross-provincial medical treatment registration in advance. This can be done online through the "National Medical Insurance Service Platform" APP or the local medical insurance bureau's official account. After registration, the reimbursement rate for treatment at a designated hospital in another location is usually 10% to 20% lower than locally, and the cap is implemented according to the policy of the insured's home region. Costs incurred without registration are generally not reimbursable.
Q3: Can the male partner's examination items be reimbursed?
Yes. Male items such as semen analysis, sperm morphology examination, sperm DNA fragmentation rate, and sex hormone tests can be reimbursed proportionally as long as they are in the medical insurance catalog and prescribed by a designated hospital. However, costs related to donor sperm (e.g., obtaining sperm from a sperm bank) are not covered by medical insurance.
Q4: How much will I still have to pay out-of-pocket after reimbursement?
Taking a Beijing employee as an example, the total cost of a conventional IVF cycle is about 35,000 RMB. Medical insurance reimburses about 18,000 to 22,000 RMB (calculated at 70% rate, after deducting the Category B self-pay portion), leaving an out-of-pocket amount of about 13,000 to 17,000 RMB. When using imported drugs or requiring PGT, the out-of-pocket amount will increase significantly. The specific amount varies greatly depending on the individual plan. It is recommended to ask the doctor or financial staff for a cost estimate when finalizing the plan.
Q5: Does medical insurance reimbursement affect the success rate?
Not at all. Medical insurance reimbursement is part of the payment process and is unrelated to medical quality, treatment plans, or laboratory conditions. The success rate mainly depends on factors such as the female partner's age, ovarian reserve function, sperm quality, and the hospital's technical level. Medical insurance policies do not interfere with clinical decisions; doctors will formulate the most suitable plan based on the patient's condition.
===== 10. Practitioner's Observations =====X. Practitioner's Observations
As a medical editor who has worked in the field of reproductive medicine for many years, I have observed several noteworthy phenomena. First, low awareness of the policy: In regions where medical insurance reimbursement has been implemented, over 40% of patients are still unaware of the specific reimbursement scope, leading to some reimbursable costs being paid out-of-pocket. Second, differences in hospital implementation: Different hospitals in the same city sometimes have slight differences in defining "reimbursable items," which is related to the hospital's medical insurance office's interpretation of the policy. Third, patients lack expectations for "Category B self-pay": Many patients see "70% reimbursement" and think they only need to pay 30%, but find the actual out-of-pocket ratio is close to 40% to 50% because the self-pay portion of Category B items was not included in the estimate.
Based on these observations, it is recommended that patients do three things before starting treatment: ① Print a personal insurance benefit statement from the medical insurance bureau's website or window to confirm your contribution status and reimbursement limit; ② When finalizing the plan, ask the doctor to mark the medical insurance category of each item (Category A/Category B/self-pay); ③ Keep all payment receipts and verify the settlement statement yourself after treatment ends. If you find that the reimbursement amount significantly differs from expectations, you can request a review from the hospital's medical insurance office or the medical insurance bureau.
===== End: Risk Reminder =====Policy Risk and Dynamic Adjustment Reminder
· Local medical insurance bureau official phone number (12393)
· Designated reproductive center medical insurance office window
· National Medical Insurance Service Platform APP (for checking cross-provincial medical treatment registration and reimbursement policies)
Furthermore, medical insurance reimbursement does not change the independence of medical decision-making. Whether a patient is suitable for IVF, which treatment plan to choose, and whether PGT is needed should all be decided by the reproductive doctor based on medical indications. Medical insurance factors should not be the primary basis for choosing a treatment plan. It is recommended to develop an individualized treatment plan with your doctor based on a full understanding of your own condition and medical insurance policy.
This article is compiled by a reproductive medicine medical editor and is intended for knowledge reference only. It does not serve as a direct basis for medical insurance reimbursement. Specific policies are subject to the latest regulations of the local medical insurance bureau and designated medical institutions.
Comments (0)